Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Hellerstein

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Psychiatric Practice|July 2, 2005
Dysthymic disorder: integrating research findings into clinical treatmentD J Hellerstein
The American Journal of Psychiatry|October 1, 1987
Outpatient group therapy for schizophrenic substance abusersD J Hellerstein, B Meehan
CNS Drugs|June 14, 2015
Current Perspectives on the Diagnosis and Treatment of Double DepressionD J Hellerstein, S A Little
General Hospital Psychiatry|January 1, 1992
Assessing HIV risk in the general hospital psychiatric clinicD J Hellerstein, M E Prager
Molecular Psychiatry|March 8, 2017
Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illnessR Bansal, D J Hellerstein, B S Peterson
The Psychiatric Quarterly|January 1, 1992
Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patternsR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|August 30, 2001
Integrating services for schizophrenia and substance abuseD J Hellerstein, R N Rosenthal, C R Miner
Journal of Clinical Psychopharmacology|June 2, 2001
Bupropion sustained-release for the treatment of dysthymic disorder: an open-label studyD J Hellerstein, S Batchelder, D Kreditor, et al.
Comprehensive Psychiatry|March 1, 1994
Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disordersR N Rosenthal, D J Hellerstein, C R Miner
The Journal of Psychotherapy Practice and Research|June 16, 2012
Supportive therapy as the treatment model of choiceD J Hellerstein, H Pinsker, R N Rosenthal, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Psychiatric Practice|July 2, 2005
Dysthymic disorder: integrating research findings into clinical treatmentD J Hellerstein
The American Journal of Psychiatry|October 1, 1987
Outpatient group therapy for schizophrenic substance abusersD J Hellerstein, B Meehan
CNS Drugs|June 14, 2015
Current Perspectives on the Diagnosis and Treatment of Double DepressionD J Hellerstein, S A Little
General Hospital Psychiatry|January 1, 1992
Assessing HIV risk in the general hospital psychiatric clinicD J Hellerstein, M E Prager
Molecular Psychiatry|March 8, 2017
Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illnessR Bansal, D J Hellerstein, B S Peterson
The Psychiatric Quarterly|January 1, 1992
Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patternsR N Rosenthal, D J Hellerstein, C R Miner
The Psychiatric Quarterly|August 30, 2001
Integrating services for schizophrenia and substance abuseD J Hellerstein, R N Rosenthal, C R Miner
Journal of Clinical Psychopharmacology|June 2, 2001
Bupropion sustained-release for the treatment of dysthymic disorder: an open-label studyD J Hellerstein, S Batchelder, D Kreditor, et al.
Comprehensive Psychiatry|March 1, 1994
Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disordersR N Rosenthal, D J Hellerstein, C R Miner
The Journal of Psychotherapy Practice and Research|June 16, 2012
Supportive therapy as the treatment model of choiceD J Hellerstein, H Pinsker, R N Rosenthal, et al.
Pageof 3